EFFECT OF FENFLURAMINE ON INSULIN/GROWTH HORMONE RATIO IN OBESE SUBJECTS

[1] BAGDADE JD, 1968, LANCET, V2, P630

[2] BAGDADE JD, 1967, J CLIN ENDOCR METAB, V34, P498

[3] EFFECT OF FENFLURAMINE ON PROLACTIN SECRETION IN OBESE PATIENTS - EVIDENCE FOR SEROTONINERGIC REGULATION OF PROLACTIN IN MAN [J]. CLINICAL ENDOCRINOLOGY, 1983, 19 (06) : 705 - 710

[4] BASERGHIAN G, 1983, EUR J PHARMACOL, V96, P53

[5] COMPARISON OF CARBOHYDRATE-CONTAINING AND CARBOHYDRATE-RESTRICTED HYPOCALORIC DIETS IN THE TREATMENT OF OBESITY - ENDURANCE AND METABOLIC FUEL HOMEOSTASIS DURING STRENUOUS EXERCISE [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (02) : 399 - 404

[6] CABEZASCERRATO J, 1978, CENTRAL MECHANISM AN, P319

[7] DEPENDING ON THE STIMULUS, CENTRAL SEROTONINERGIC ACTIVATION BY FENFLURAMINE BLOCKS OR DOES NOT ALTER GROWTH-HORMONE SECRETION IN MAN [J]. NEUROENDOCRINOLOGY, 1984, 38 (04) : 302 - 308

[8] RELATIONS BETWEEN IMMUNOREACTIVE SOMATOMEDIN-C, INSULIN AND T3 PATTERNS DURING FASTING IN OBESE SUBJECTS [J]. CLINICAL ENDOCRINOLOGY, 1984, 20 (01) : 65 - 70

[9] THE RESPONSE OF OBESE SUBJECTS TO CONTINUOUS INFUSION OF HUMAN PANCREATIC GROWTH HORMONE-RELEASING FACTOR-1-44 [J]. CLINICAL ENDOCRINOLOGY, 1985, 23 (05) : 521 - 525

[10] INFLUENCE OF FENFLURAMINE ON ORAL GLUCOSE-TOLERANCE TESTS, PLASMA SUGAR AND INSULIN LEVELS IN NEWLY DIAGNOSED LATE-ONSET DIABETIC-PATIENTS [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1979, 6 : 247 - 254

[1] BAGDADE JD, 1968, LANCET, V2, P630

[2] BAGDADE JD, 1967, J CLIN ENDOCR METAB, V34, P498

[3] EFFECT OF FENFLURAMINE ON PROLACTIN SECRETION IN OBESE PATIENTS - EVIDENCE FOR SEROTONINERGIC REGULATION OF PROLACTIN IN MAN [J]. CLINICAL ENDOCRINOLOGY, 1983, 19 (06) : 705 - 710

[4] BASERGHIAN G, 1983, EUR J PHARMACOL, V96, P53

[5] COMPARISON OF CARBOHYDRATE-CONTAINING AND CARBOHYDRATE-RESTRICTED HYPOCALORIC DIETS IN THE TREATMENT OF OBESITY - ENDURANCE AND METABOLIC FUEL HOMEOSTASIS DURING STRENUOUS EXERCISE [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (02) : 399 - 404

[6] CABEZASCERRATO J, 1978, CENTRAL MECHANISM AN, P319

[7] DEPENDING ON THE STIMULUS, CENTRAL SEROTONINERGIC ACTIVATION BY FENFLURAMINE BLOCKS OR DOES NOT ALTER GROWTH-HORMONE SECRETION IN MAN [J]. NEUROENDOCRINOLOGY, 1984, 38 (04) : 302 - 308

[8] RELATIONS BETWEEN IMMUNOREACTIVE SOMATOMEDIN-C, INSULIN AND T3 PATTERNS DURING FASTING IN OBESE SUBJECTS [J]. CLINICAL ENDOCRINOLOGY, 1984, 20 (01) : 65 - 70

[9] THE RESPONSE OF OBESE SUBJECTS TO CONTINUOUS INFUSION OF HUMAN PANCREATIC GROWTH HORMONE-RELEASING FACTOR-1-44 [J]. CLINICAL ENDOCRINOLOGY, 1985, 23 (05) : 521 - 525

[10] INFLUENCE OF FENFLURAMINE ON ORAL GLUCOSE-TOLERANCE TESTS, PLASMA SUGAR AND INSULIN LEVELS IN NEWLY DIAGNOSED LATE-ONSET DIABETIC-PATIENTS [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1979, 6 : 247 - 254